Reuters logo
BRIEF-Puma Biotechnology receives FDA advisory committee support for Neratinib
May 24, 2017 / 5:47 PM / 4 months ago

BRIEF-Puma Biotechnology receives FDA advisory committee support for Neratinib

May 24 (Reuters) - Puma Biotechnology Inc

* Puma biotechnology receives fda advisory committee support for neratinib

* Says U.S. FDA oncologic drugs advisory committee voted 12 - 4 to recommend approval of pb272 (Neratinib)

* Says focus of meeting with the advisory committee was phase iii extenet study

* Says study demonstrated statistically significant 33% relative reduction of risk of invasive disease recurrence within 2 yrs after treatment Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below